In terms of provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and Company’s Code of Conduct to regulate, monitor and report trading by Designated Persons, Parmax Pharma has informed that the Trading Window for dealing in securities of the Company by Designated Persons shall remain closed from July 01, 2026 till 48 hours after the declaration of the financial results for the quarter ending on June 30, 2026 for all designated persons of the Company. The date of the Board Meeting at which the said results will be considered shall be intimated in due course of time.
The above information is a part of company’s filings submitted to BSE.
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: